Why must the debate continue on Krabbe disease newborn screening?

Area of Science:

• Neurology
• Genetics
• Public Health

Background:

• Krabbe disease is a rare, fatal neurological disorder impacting families since the early 2000s.
• Grassroots efforts for state-level newborn screening have faced significant challenges.
• Barriers include poor testing mechanisms, limited understanding of transplantation outcomes, and low incidence rates.

Purpose of the Study:

• To highlight the ongoing challenges in implementing newborn screening for Krabbe disease.
• To underscore the progress made by organizations and experts in meeting screening eligibility requirements.
• To address the continued disregard of community advancements by ethicists and advisory committees.

Main Methods:

• Review of grassroots advocacy efforts for Krabbe disease newborn screening.
• Analysis of factors hindering state adoption of screening protocols.
• Assessment of progress towards inclusion in the Recommended Uniform Screening Panel (RUSP).

Main Results:

• Despite advancements in treatment and screening protocols over the past five years, state-level agreement remains elusive.
• Ethicists and newborn screening advisory committees have not fully acknowledged the progress made.
• Families continue to face obstacles in establishing comprehensive newborn screening for Krabbe disease.

Conclusions:

• Significant strides have been made by organizations and experts to advance Krabbe disease screening.
• Continued advocacy and education are crucial to overcome persistent barriers and ensure equitable access to newborn screening.
• Addressing the concerns of ethicists and advisory committees requires demonstrating robust evidence of improved outcomes and reliable testing mechanisms.